Abstract |
A series of opioid and serotonin re-uptake inhibitors ( SSRIs) bifunctional ligands have been designed, synthesized, and tested for their activities and efficacies at μ-, δ- and κ opioid receptors and SSRIs receptors. Most of the compounds showed high affinities for μ- and δ- opioid receptors and lower affinities for SSRIs and κ opioid receptors. A docking study on the μ- opioid receptor binding pocket has been carried out for ligands 3-11. The ligands 7 and 11 have displayed the highest binding profiles for the μ- opioid receptor binding site with ΔGbind (-12.14kcal/mol) and Ki value (1.0nM), and ΔGbind (-12.41kcal/mol) and Ki value (0.4nM), respectively. Ligand 3 was shown to have the potential of dual acting serotonin/ norepinephrine re-uptake inhibitor ( SNRI) antidepressant activity in addition to opioid activities, and thus could be used for the design of multifunctional ligands in the area of a novel approach for the treatment of pain and depression.
|
Authors | Mehr-un-Nisa, Munawar A Munawar, Yeon Sun Lee, David Rankin, Jawaria Munir, Josephine Lai, Misbahul A Khan, Victor J Hruby |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 23
Issue 6
Pg. 1251-9
(Mar 15 2015)
ISSN: 1464-3391 [Electronic] England |
PMID | 25703306
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2015 Elsevier Ltd. All rights reserved. |
Chemical References |
- Ligands
- Receptors, Opioid
- Receptors, Serotonin
- Serotonin Uptake Inhibitors
|
Topics |
- Dose-Response Relationship, Drug
- Drug Design
- Humans
- Ligands
- Molecular Structure
- Receptors, Opioid
(metabolism)
- Receptors, Serotonin
(metabolism)
- Selective Serotonin Reuptake Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Structure-Activity Relationship
|